• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衡量国家免疫体系绩效:现有资源的系统评估。

Measuring National Immunization System Performance: A Systematic Assessment of Available Resources.

机构信息

National Centre for Epidemiology and Population Health, Australian National University, Acton, Australia.

World Health Organization, Seoul, Republic of Korea.

出版信息

Glob Health Sci Pract. 2023 Jun 21;11(3). doi: 10.9745/GHSP-D-22-00555.

DOI:10.9745/GHSP-D-22-00555
PMID:37348935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10285727/
Abstract

BACKGROUND

Vaccination coverage is widely used to assess immunization performance but, on its own, provides insufficient information to drive improvements. Assessing the performance of underlying components of immunization systems is less clear, with several monitoring and evaluation (M&E) resources available for use in different operational settings and for different purposes. We studied these resources to understand how immunization system performance is measured.

METHODS

We reviewed peer-reviewed and gray literature published since 2000 to identify M&E resources that include national-level indicators measuring the performance of immunization systems or their components (governance, financing, regulation, information systems, vaccine logistics, workforce, service delivery, and demand generation). We summarize indicators by the system components or outcomes measured and describe findings narratively.

RESULTS

We identified 20 resources to monitor immunization program objectives and guide national strategic decision-making, encompassing 631 distinct indicators. Indicators for immunization program outcomes comprised the majority (124/631 [19.7%]), largely vaccination coverage (110/124 [88.7%]). Almost all resources (19/20 [95%]) included indicators for vaccine logistics (83/631 [13.2%]), and those for regulation (19/631 [3.0%]) and demand generation (28/631 [4.4%]) were least common. There was heterogeneity in how information systems (92/563 [14.6%]) and workforce (47/631 [7.4%]) were assessed across resources. Indicators for vaccination coverage in adults, data use in decision-making, equity and diversity, effectiveness of safety surveillance, and availability of a public health workforce were notably lacking.

CONCLUSIONS

Between the resources identified in this review, we identified considerable variability and gaps in indicators assessing the performance of some immunization system components. Given the multitude of indicators, policymakers may be better served by tailoring evaluation resources to their specific context to gain useful insight into health system performance and improve data use in decision-making for immunization programs.

摘要

背景

疫苗接种覆盖率被广泛用于评估免疫接种效果,但仅靠这一指标并不能提供足够的信息来推动改进。评估免疫接种系统的基本组成部分的效果则不那么明确,有几种监测和评估 (M&E) 资源可用于不同的运作环境和不同的目的。我们研究了这些资源,以了解如何衡量免疫接种系统的绩效。

方法

我们回顾了 2000 年以来发表的同行评议和灰色文献,以确定包括国家层面指标的 M&E 资源,这些指标衡量免疫接种系统或其组成部分(治理、融资、监管、信息系统、疫苗物流、劳动力、服务提供和需求产生)的绩效。我们根据所测量的系统组成部分或结果对指标进行总结,并进行叙述性描述。

结果

我们确定了 20 种资源来监测免疫规划目标并指导国家战略决策,其中包含 631 个不同的指标。免疫规划结果指标占大多数(124/631 [19.7%]),主要是疫苗接种覆盖率(110/124 [88.7%])。几乎所有资源(19/20 [95%])都包含疫苗物流指标(83/631 [13.2%]),而监管指标(19/631 [3.0%])和需求产生指标(28/631 [4.4%])则较少。各资源之间在信息系统(92/563 [14.6%])和劳动力(47/631 [7.4%])的评估方法上存在差异。成人疫苗接种覆盖率、决策中的数据使用、公平性和多样性、安全性监测的有效性以及公共卫生劳动力的可用性等方面的指标明显缺乏。

结论

在本次审查中确定的资源中,我们发现一些免疫接种系统组成部分的绩效评估指标存在相当大的差异和差距。鉴于指标众多,政策制定者可能会更好地根据其特定情况来调整评估资源,以便从免疫规划的角度深入了解卫生系统的绩效并改善决策中的数据使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc48/10285727/31d287144926/GH-GHSP230059F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc48/10285727/31d287144926/GH-GHSP230059F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc48/10285727/31d287144926/GH-GHSP230059F001.jpg

相似文献

1
Measuring National Immunization System Performance: A Systematic Assessment of Available Resources.衡量国家免疫体系绩效:现有资源的系统评估。
Glob Health Sci Pract. 2023 Jun 21;11(3). doi: 10.9745/GHSP-D-22-00555.
2
Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.维持儿童免疫接种成功的策略。国家疫苗咨询委员会。
JAMA. 1999 Jul 28;282(4):363-70. doi: 10.1001/jama.282.4.363.
3
Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.通过整合现有的公共卫生基础设施,在国家免疫规划中成功引入一种未得到充分利用的老年肺炎球菌疫苗。
Vaccine. 2016 Mar 18;34(13):1623-1629. doi: 10.1016/j.vaccine.2016.01.043. Epub 2016 Feb 3.
4
Strengthening vaccination policies in Latin America: an evidence-based approach.加强拉丁美洲的疫苗接种政策:循证方法。
Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.
5
Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.推进国家免疫规划:在中国乃至全球实现疫苗全覆盖的时代
Infect Dis Poverty. 2024 Mar 13;13(1):25. doi: 10.1186/s40249-024-01192-6.
6
Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.更新当前和未来加速疾病控制、消除和根除努力的补充免疫活动运营成本的证据基础。
BMC Public Health. 2014 Jan 22;14:67. doi: 10.1186/1471-2458-14-67.
7
Assessment of vaccination service delivery and quality: a cross-sectional survey of over 1300 health facilities from 29 districts in Sindh, Pakistan conducted between 2017-18.评估疫苗接种服务提供和质量:2017-18 年在巴基斯坦信德省 29 个地区的 1300 多家卫生机构进行的横断面调查。
BMC Health Serv Res. 2022 Jun 1;22(1):727. doi: 10.1186/s12913-022-08098-9.
8
Improving immunization capacity in Ethiopia through continuous quality improvement interventions: a prospective quasi-experimental study.通过持续质量改进干预提高埃塞俄比亚的免疫能力:一项前瞻性准实验研究。
Infect Dis Poverty. 2018 Nov 30;7(1):119. doi: 10.1186/s40249-018-0502-8.
9
Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization.提高免疫和监测数据的质量和利用:免疫战略咨询专家组工作组的总结报告。
Vaccine. 2020 Oct 27;38(46):7183-7197. doi: 10.1016/j.vaccine.2020.09.017. Epub 2020 Sep 17.
10
Incorporating costing study results into district and service planning to enhance immunization programme performance: a Zambian case study.将成本研究结果纳入地区和服务规划以提高免疫规划绩效:赞比亚案例研究。
Health Policy Plan. 2019 Jun 1;34(5):327-336. doi: 10.1093/heapol/czz039.

引用本文的文献

1
The association between routine immunisation and COVID-19 vaccination in small Island developing states.小岛屿发展中国家常规免疫与新冠疫苗接种之间的关联。
PLoS One. 2025 Jul 8;20(7):e0317327. doi: 10.1371/journal.pone.0317327. eCollection 2025.
2
Strengthening Immunization Data: Protocol for the Evaluation of an Electronic Immunization Register.加强免疫接种数据:电子免疫接种登记册评估方案
JMIR Res Protoc. 2025 Jun 19;14:e65663. doi: 10.2196/65663.
3
Does unintended birth lead to zero dose of DPT vaccine among children aged 12-23 months in India?

本文引用的文献

1
Immunization agenda 2030: A global strategy to leave no one behind.《2030年免疫议程:不让任何人掉队的全球战略》
Vaccine. 2024 Apr 8;42 Suppl 1:S5-S14. doi: 10.1016/j.vaccine.2022.11.042.
2
Root Causes of Poor Immunisation Data Quality and Proven Interventions: A Systematic Literature Review.免疫接种数据质量低下的根本原因及已证实的干预措施:一项系统文献综述
Ann Infect Dis Epidemiol. 2017 Feb 27;2(1):1-7.
3
Achieving the IA2030 Coverage and Equity Goals through a Renewed Focus on Urban Immunization.通过重新聚焦城市免疫接种实现2030年免疫接种覆盖和公平目标。
在印度,12-23 月龄儿童中未计划生育是否会导致其完全未接种 DPT 疫苗?
Hum Vaccin Immunother. 2024 Dec 31;20(1):2417526. doi: 10.1080/21645515.2024.2417526. Epub 2024 Nov 7.
4
Measuring what matters: Context-specific indicators for assessing immunisation performance in Pacific Island Countries and Areas.衡量关键指标:太平洋岛国和地区评估免疫规划绩效的特定背景指标
PLOS Glob Public Health. 2024 Jul 25;4(7):e0003068. doi: 10.1371/journal.pgph.0003068. eCollection 2024.
5
Establishing a Framework for Evaluating the Effectiveness of Vaccines Targeting National Vaccination Programs.建立评估针对国家疫苗接种计划的疫苗有效性的框架。
J Korean Med Sci. 2024 Jul 1;39(25):e193. doi: 10.3346/jkms.2024.39.e193.
6
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.疫苗的药物警戒:重要性、主要方面、前景与挑战——一篇叙述性综述
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
Vaccines (Basel). 2023 Apr 6;11(4):809. doi: 10.3390/vaccines11040809.
4
Data quality of reported child immunization coverage in 194 countries between 2000 and 2019.2000年至2019年间194个国家报告的儿童免疫接种覆盖率的数据质量。
PLOS Glob Public Health. 2022 Feb 3;2(2):e0000140. doi: 10.1371/journal.pgph.0000140. eCollection 2022.
5
How do we design and evaluate health system strengthening? Collaborative development of a set of health system process goals.我们如何设计和评估卫生系统强化?一组卫生系统过程目标的协作式制定。
Int J Health Plann Manage. 2023 Mar;38(2):279-288. doi: 10.1002/hpm.3607. Epub 2022 Dec 28.
6
Why does gender matter for immunization?为什么性别对免疫接种很重要?
Vaccine. 2024 Apr 8;42 Suppl 1(Suppl 1):S91-S97. doi: 10.1016/j.vaccine.2022.11.071. Epub 2022 Dec 10.
7
Routine Vaccination Coverage - Worldwide, 2021.常规疫苗接种覆盖率-全球,2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1396-1400. doi: 10.15585/mmwr.mm7144a2.
8
Resolving sex and gender bias in COVID-19 vaccines R&D and beyond.解决 COVID-19 疫苗研发及其他领域中的性别偏见问题。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2035142. doi: 10.1080/21645515.2022.2035142. Epub 2022 Feb 10.
9
Impact of health system strengthening on delivery strategies to improve child immunisation coverage and inequalities in rural Madagascar.卫生系统强化对改善马达加斯加农村地区儿童免疫接种覆盖率和不平等的分娩策略的影响。
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-006824.
10
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories.2019冠状病毒病大流行对常规免疫服务的影响:来自170个国家和地区的服务中断及恢复情况证据
Lancet Glob Health. 2022 Feb;10(2):e186-e194. doi: 10.1016/S2214-109X(21)00512-X. Epub 2021 Dec 21.